Award

1R01AR073004

Funder: U.S. Department of Defense

Funded outputs count: 5

Funder award ID: 1R01AR073004

OpenAlex ID: G4113206229

Correction: Janjetovic et al. Novel Vitamin D3 Hydroxymetabolites Require Involvement of the Vitamin D Receptor or Retinoic Acid-Related Orphan Receptors for Their Antifibrogenic Activities in Human Fibroblasts. Cells 2024, 13, 239

2026 · Zorica Janjetovic, Shariq Qayyum, et al. · Cells

Promising Functions of Novel Vitamin D Derivatives as Cosmetics: A New Fountain of Youth in Skin Aging and Skin Protection

2024 · Zorica Janjetovic, Andrzej T. Slominski · Cosmetics · 19

Novel Vitamin D3 Hydroxymetabolites Require Involvement of the Vitamin D Receptor or Retinoic Acid-Related Orphan Receptors for Their Antifibrogenic Activities in Human Fibroblasts

2024 · Zorica Janjetovic, Shariq Qayyum, et al. · Cells · 11

Melatonin and Its Metabolites Can Serve as Agonists on the Aryl Hydrocarbon Receptor and Peroxisome Proliferator-Activated Receptor Gamma

2023 · Andrzej T. Slominski, Tae-Kang Kim, et al. · International Journal of Molecular Sciences · 66

Editorial: Role of pigmentation in melanoma

2022 · Anna A. Brożyna, Laura Poliseno, et al. · Frontiers in Oncology · 2